No abstract available
Keywords: COVID-19; Microparticles; PF4; Thrombocytopenia; Thrombosis; Vaccine.
MeSH terms
- Ad26COVS1
- Autoantibodies / blood
- Blood Coagulation / drug effects*
- Blood Platelets / drug effects*
- Blood Platelets / immunology
- Blood Platelets / metabolism
- COVID-19 Vaccines / administration & dosage
- COVID-19 Vaccines / adverse effects*
- Cell-Derived Microparticles / drug effects*
- Cell-Derived Microparticles / immunology
- Cell-Derived Microparticles / metabolism
- ChAdOx1 nCoV-19
- Female
- Humans
- Male
- Middle Aged
- Phosphatidylserines / metabolism
- Platelet Factor 4 / immunology
- Purpura, Thrombocytopenic, Idiopathic / blood
- Purpura, Thrombocytopenic, Idiopathic / chemically induced*
- Purpura, Thrombocytopenic, Idiopathic / diagnosis
- Purpura, Thrombocytopenic, Idiopathic / immunology
- Receptors, IgG / metabolism
- Risk Factors
- Sinus Thrombosis, Intracranial / blood
- Sinus Thrombosis, Intracranial / chemically induced*
- Sinus Thrombosis, Intracranial / diagnosis
- Thromboplastin / metabolism
- Vaccination / adverse effects*
Substances
- Ad26COVS1
- Autoantibodies
- COVID-19 Vaccines
- FCGR2A protein, human
- PF4 protein, human
- Phosphatidylserines
- Receptors, IgG
- Platelet Factor 4
- Thromboplastin
- ChAdOx1 nCoV-19